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Histamin und Ulkuskrankheit 
Zusammenfassung. In einer prospektiven Studie 
wurde der Histamingehalt der Korpusschleimhaut bei 
100 Patienten gemessen. Diese Patienten schliel3en 
Kontrollpersonen, Ulkus-duodeni-Trfiger und solche 
mit verschiedenen gastrointestinalen Erkrankungen 
ein. Der Histamingehalt betrug 43 I~g/g bei Kontroll- 
personen und war bei Ulkus-duodeni-Kranken signi- 
fikant um 30% erniedrigt. Alle anderen Patienten- 
gruppen wiesen ,,normale" Histamingehalte in der 
Magenschleimhaut auf. Da es bei allen S/iugerarten 
mit Ausnahme der Ratte fiul3erst schwierig ist, den 
Histamingehalt der Magenschleimhaut durch irgend- 
eine Mal3nahme zu vergndern, erscheint die Ab- 
nahme des Histamingehaltes der Korpusschleimhaut 
beim Ulkus duodeni besonders bemerkenswert. Unter 
verschiedenen Hypothesen gilt als wahrscheinlichste 
eine vermehrte Histaminfreisetzung beimchronischen 
Ulkus duodeni. 
Sehliisseiwiirter: Histamingehalt - Magenschleim- 
haut - Ulkus duodeni - Gastrointestinale Erkran- 
kungen - Histaminfreisetzung. 
Summary. In a prospective study the histamine con- 
tent of the mucosa of the body of the stomach was 
measured in 100 patients consisting of control sub- 
jects, patients with duodenal ulcer and patients uffer- 
ing from various gastrointestinal diseases. The hista- 
mine content was found to be 43 gg/g in male control 
subjects (median) while in duodenal ulcer patients 
levels attained were significantly lower by about 30 
per cent. In all the other groups of patients histamine 
concentrations in gastric mucosa were found to be 
"normal" .  Since in most species it is extremely diffi- 
* Presented at the meeting on "Gastric and duodenal ulcer dis- 
ease: Basic principles and clinics of treatment by drugs and oper- 
ations", Marburg, November 22, t975 
** Supported by the Deutsche Forschungsgemeinschaft (Lo 199/5) 
cult to alter the mucosal histamine concentration by 
any form of treatment, he diminished histamine con- 
tent of the gastric mucosa in patients with duodenal 
ulcer seems remarkable. Among several possible 
explanations offered for this finding we think the most 
likely is that histamine release is increased in duodenal 
ulcer disease. 
Key words: Histamine content - Gastric mucosa - 
Duodenal ulcer - Gastrointestinal disease - Hista- 
mine release. 
Clinical observations and experimental findings alike 
justify the hypothesis that nervous and humoral stim- 
ulants of gastric acid secretion are factors in the pa- 
thogenesis of chronic duodenal ulcer disease. Three 
basic arguments, for instance, have been advanced 
in favour of a role played by the vagus nerve (Drag- 
stedt, 1962): continuous hypersecretion is observed 
in human duodenal ulcer disease; vagotomy abolishes 
the fasting hypersecretion and heals ulcers. Similar 
arguments can be found for a role for the family 
of gastrins, since continuous infusion of pentagastrin 
produces ulcers in cats (Konturek et al., 1973) and 
hypergastrinaemia in the Zollinger-Ellison syndrome 
is accompanied by peptic ulcer disease (Ellison and 
Wilson, 1964). 
Histamine has long been a candidate for inclusion 
in this exclusive club of ulcer-promoting factors (Bab- 
kin, 1950). Thus chronic or continuous application 
of histamine produces ulcers in animals (Biichner 
et al., 1928; Walpote et at., 1940). When gastrin was 
isolated, however, histamine went out of fashion in 
gastric physiology (Johnson, 1971) and for a time 
it seemed that the vagus and gastrin were, together, 
sufficient o account for the genesis of peptic ulcers. 
Interest in histamine was re-awakened by the intro- 
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duction of histamine H2-receptor antagonists by 
Black et al. (1972, 1973). These drugs inhibit both 
fasting and stimulated gastric secretion and promote 
the healing of peptic ulcers in man (multicentre trial, 
1975). The interpretation of these findings is still dis- 
puted, however, and not necessarily has to include 
histamine as a physiological or pathophysiological 
intermediary in the stimulation of gastric secretion 
(Grossman and Konturek, 1973). Certainly, the argu- 
ments in favour of a role for histamine- namely that 
histamine induces ulcers in animals and that H2-re- 
ceptor antagonists heal duodenal ulcers in man-ap-  
pear just as cogent as the arguments advanced in 
favour of the gastrins and the vagus. 
Certain conditions have to be satisfied, in our 
opinion, before histamine can be accepted as an ae- 
tiological factor in duodenal ulcer disease: (1) hista- 
mine alone or in combination with other gastric secre- 
tory stimulants hould be shown to produce experi- 
mental ulcers, (2) in the gastric mucosa around the 
parietal cells,free histamine should occur continuous- 
ly in concentrations higher than normal in order to 
induce fasting hypersecretion, (3) in the duodenum, 
free histamine should be present as in gastric mucosa, 
contributing to the pathogenesis of peptic ulcer by 
influencing the release of inhibitory hormones uch 
as secretin, and by altering the microcirculation. His- 
tamine has been shown to be capable of releasing 
gastrin (Fielding et al., t974), insulin (Vance and 
Bragg, 1969) and pituitary hormones (Harris et al., 
1952) and its actions on the microcirculation have 
been studied intensively (Schayer, 1961). 
There are several speculative mechanisms by 
which free histamine levels might be elevated around 
the parietal cell: (1) increased plasma histamine 
concentrations may occur in liver insufficiency and 
portacaval shunting, but have been demonstrated 
conclusively only in acute situations such as after 
drug administration and operations (Lorenz et al., 
1972; Lorenz et al., 1974; Lorenz, 1976), (2) histamine 
may be released from gastric mast cell stores in abnor- 
mally large amounts by gastric stimulants, (3) en- 
hanced formation of (induced?) histamine may be 
elicited by various nervous and humoral factors (for 
a review see Lorenz and Pfleger, 1968), (4) finally, 
the inactivation of histamine may be decreased by 
influences on histamine methyltransferase activity 
(Troidl et al., 1973 ; Barth et al., 1975) or on histamine 
uptake (Lorenz et al., 1975). 
At present it isnot possible to measure the concen- 
tration of free histamine around human parietal cells 
in vivo. In order to investigate this problem, however, 
we have determined the concentration of stored hista- 
mine in human corpus mucosa, which may provide 
a guide to histamine release as it does in certain 
"acute" situations (Kahlson et al., 1964). A prospec- 
tive study was therefore performed in 100 patients 
at our hospital, preliminary results have already been 
published (Troidl et al., 1976 a, 1976 b). 
Materials and Methods 
Materials 
Design and Protocols f the Study. In a prospective study biopsies 
of gastric mucosa for histamine stimation were taken in 100 pa- 
tients from Marburg and surroundings (Nordhessen). The study 
ran from April 30th, 1973 till September 9th, 1973, and, at the 
exception of the radiological and microscopical examinations it
was carried out exclusively by our working group for gastric 
disease. This group for the purposes of the study, consisted of 
two clinical surgeons, two theoretical surgeons (for definition see 
Lorenz et al., 1976a), four technicians and one medical student. 
The various parts of the study (Table 1) were performed in 
a special suite of rooms, at definite times and always by the same 
investigators and technicians. 
(1) Photostat copies were made of the patients' case histories, 
which had been completed strictly from data provided by the family 
doctors and by other hospitals where the patients had previously 
been treated. In this way no information was lost during the routine 
work at our clinic. In three cases only earlier findings in other 
hospitals provided the diagnosis, because due to spontaneous heal- 
ing of duodenal ulcers the lesions could no longer be demonstrated 
at our hospital. The clinical questionnaire was completed at our 
follow-up clinic (Rohde et al., 1976a). 
(2) Fibre-gastroscopy was performed by the two clinical sur- 
geons in the morning on Monday and Wednesday each week. 
Table l . Design and protocols of the prospective study on mucosal 
histamine concentration i various gastric diseases 
1. Findings obtained by 
- case history (completed by data from other hospitals) 
- clinical questionnaire with 60 questions 
- oesophago-gastro-duodenoscopy 
- microscopical examination of biopsy specimens from 
oesophagus, tomach and duodenum 
- rad io Iogy  of stomach, intestine and biliary tract 
- gastric secretory tests 
- operative findings in all cases submitted to surgery 
2. Diagnoses established by 
- preliminary decision made by two clinical surgeons and 
by one theoretical surgeon independently of each other 
- final decision made by a panel discussion of the three 
investigators 
3. Control subjects and patients classified by 
- present diagnosis 
accompanying diseases 
-, earlier history 
4. Parameters investigated in the study 
- Histamine concentration of corpus mucosa 
- Basal secretion and maximum secretory response to 
pentagastrin: a Volume acidity, acid output, pepsin output 
a The results on these parameters will be published in forthcoming 
papers 
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All patients ubmitted to this procedure for diagnostic purposes 
(none under emergency conditions) were included, without any 
special selection of cases. By design, also patients with insignificant, 
but undiagnosed, abdominal complaints were included in the trial 
so that we might obtain control subjects. The decision in favour 
of endoscopy, however, in these patients was made by physicians 
not involved in this study (they belonged to" other sections of 
our clinic or to other departments). There was no seletion of sub- 
jects according to the day of the week, so as to have, for example 
more endoscopies onduodenal ulcer patients on Monday and more 
iu other groups of patients on Wednesday. Hence members of 
tile different groups of patients were likely to have been distributed 
randomly in our sample, they could so be used as controls for 
the duodenal ulcer patients because they were subjected to the 
same physical and psychological stresses. The criterion used to 
include subjects in the trial was the performance of endoscopy, 
since in each of a consecutive series of 100 patients ubmitted 
to this procedure, biopsy specimens were taken for the determina- 
tion of mucosal histamine concentration. 
(3) Microscopical examination of the biopsy specimens was 
performed at the Department ofPathology, Marburg, and radiolo- 
gy at a division of our Department of Surgery following a barium 
meal and administration of iodine benzamic acid (Osbil ®, Byk- 
Gulden, Konstanz). 
(4) According to the procedure shown in Table 1, the diagnoses 
were established separately by each of the three investigators. 
(5) Following the final decision reached uring a panel discus- 
sion, the patients were integrated into one of several groups of 
patients (Table 2) on the basis of the present diagnosis, the ac- 
companying diseases and the diseases found earlier in the case 
history. Their earlier case history sometimes led to considerable 
problems in classifying them as "control" or "duodenal ulcer pa- 
tient". A gastrointestinal disease in earlier life for example might 
have caused biochemical or morphological alterations n the gastric 
mucosa which may have continued to exist over the years and 
influenced the histamine content of the gastric mucosa in this 
study. 
For this and other reasons, 17 subjects were excluded from 
the study by an escape clause b cause: (1) they could not be reliably 
assigned to one of the groups in Table 2; (2) several diseases 
co-existed and none could be definitely identified as the main dis- 
ease; (3) the case history was incomplete (foreign worker); (4) 
patients had been submitted to gastric surgery before the start 
of the trial. Details of each of cases excluded are given in Table 3. 
To avoid the introduction of bias the results of the histamine 
estimations were not recorded until the patients became part of 
the one or the other group shown in Table 2. 
Definitions of Control Subjects and Patients (Table 2) 
Control Subjects. These patients were considered as "healthy" with 
respect to their upper gastrointestinal tract. (1) They were submit- 
ted to endoscopy for investigation of non-specific abdominal com- 
plaints. (2) Disease of the oesophagus, stomach and duodenal bulb 
could be excluded by endoscopy and microscopical examination 
of biopsy specimens. (3) Other diagnostic procedures, uch as ra- 
diology, clinical investigation and clinical-chemical tests also did 
not reveal any disease of the upper gastro-intestinal tract like signif- 
icant hiatal hernia (see below), cholecystitis or pancreatitis. (4) 
The time-course oftheir disease xcluded an upper gastro-intestinal 
illness, but like other groups of patients in our study the control 
subjects fully underwent the emotional stress of the hospital atmo- 
sphere. (5) The final diagnoses inthe control subjects were: insignif- 
icant hiatal hernia (10), constipation (5), dietary indiscretion (3), 
"nervous tomach" (3), adhesions after appendectomy (3), diseases 
of rectum (3) [2 carcinomas, 1 haemorrhoids], aorto-femoral bypass 
(1), sigmoid stenosis (1), umbilical hernia (1), possible trauma of 
the intestine (1). 
Duodenal Ulcer Patients. The diagnosis of duodenal ulceration was 
established in each patient, usually by all tile procedures listed 
in Table 1, and at least by endoscopic, radiological nd histological 
examination. Accompanying diseases of the upper gastrointestinal 
tract were excluded but the presence of small and insignificant 
hiatal hernias was ignored for purposes of classification. 
Gastric Ulcer Patients. In all cases the diagnosis was established 
not only by endoscopy, radiology and histology but also by oper- 
ation and intra-operative frozen section microscopical examination 
(to exclude carcinoma !).
Hiatal Hernia Patients. Hiatal hernia of insignificant degree ar  
considered as an anomaly frequently occurring with more or less 
Table 2. Attributes of "controt subjects" and patients included in the trial. The ages of female control 
subjects ranged from 24 to 76 years. 5 patients who were not operated upon and 12 following gastric 
surgery were not included and are described in Table 3 
Diagnoses Number Sex Age (Range) Weight (Range) 
of subjects (years) (kg) 
investigated Male Female 
Control subjects 31 21 10 1%81 69-110 
Duodenal ulcer 18 17 1 19-74 47-96 
Gastric ulcer 10 9 1 39-87 47-61 
Hiatat hernia 6 2 4 53-84 57-93 
Gastric carcinoma 5 5 0 43-78 48-75 
Cholecystitis 4 0 4 35-60 65-80 
Gastric erosions 3 2 1 25-66 52-84 
Zollinger-Ellison Syndrome 1 1 0 36 50 
Atrophic gastritis 1 0 1 72 52 
Pancreatitis 1 1 0 17 95 
Oesophageal varices due to 1 1 0 27 65 
portal vein cavernoma 
Alimentary obesity 2 2 0 24; 32 t44; 155 
Total 83 61 22 17-87 47-155 
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Table 3. Attributes and mucosal histamine concentrations of patients excluded from the trial by escape clause, c~ male; 9=female, 
-means  "no significant disease". Concerning the criteria for exclusion, see text in section 1 of Materials and Methods. Vagotomy= 
selective gastric vagotomy and pyloroplasty, B I or B II = Billroth I or II enteroanastomosis, 2/3-resection and antrectomy, all operations 
as described by Seidel et al. (1973), patients after operation came to our follow-up clinic 
Name Sex Age Weight Diagnoses Mucosal hista- 
(years) (kg) mine content 
present accompanying earlier (gg/g) 
Patients not operated (escape criteria 1-3) 
B.F. ~ 39 65 Scar in duodenal bulb Unknown Unknown 30.4 
B.P. ~ 43 72 Chronic liver disease Atrophic gastritis - 14.4 
Schw.W. 6` 43 68 Oesophagitis ulcerosa Pancreatitis - 28.7 
Sch.H. 6' 36 91 Intrapyloric ulcer - Cholecystitis 78.7 
W.H. 6` 17 95 Duodenal ulcer Pancreatitis, alcoholism - 40.3 
Patients having undergone gastric surgery (escape criterion 4) 
E.K. ~' 35 87 Vagotomy - Duodenal ulcer 63.5 
K.K. 6` 41 62 Vagotomy Duodenal ulcer 51.6 
K.M. 6` 67 56 Vagotomy - Duodenal ulcer 47.9 
R.H. 6` 35 72 Vagotomy cholecystitis Duodenal ulcer I02.0 
Sch.J. 6` 68 74 Vagotomy - Duodenal ulcer 49.7 
T.A. c~ 67 69 Vagotomy - Duodenal ulcer 68.8 
P.E. 6` 43 75 Recurrent ulcer (vagotomy) - Duodenal ulcer 35.0 
C.M. ~ 47 50 Vagotomy+antrectomy (BII) - Duodenal ulcer 70.7 
T.E. ~ 52 62 2/3-resection (B I) - Gastric ulcer 63.5 
G.J. 6` 48 63 Reoperation (B II) - Jejunal ulcer 9.8 
N.A. 6` 71 56 2/3-resection (B II) Cholecystectomy Gastric ulcer 57.0 
Sch.R. 9 45 72 2/3-resection (B II) - Duodenal ulcer 41.1 
Total: 16 6`, 17-71 5045 12 operated, 4 patients with Operations 
17 patients 1 9 7 vagotomies, significant accompanying mainly for 
5 gastric resections diseases duodenal ulcer 
9.8-i02.0 
remarkable complaints (Salter, i975). Thus this diagnosis was only 
accepted for classification i  patients if it was thought very likely 
to be the dominant reason for the abdominal complaints. The 
complaints, especially during the night (Earlam, 1976), had to be 
so intense as to render treatment mandatory. The diagnosis of 
hiatal hernia was made using data from the case history, clinical 
examination, endoscopy and radiology (Salter, 1975). 
Other Groups of Patients. The diagnosis and classification were 
accomplished by the method outlined in Table 1, as well as by 
common clinical-chemical tests. The diagnosis of Zotlinger-Ellison 
syndrome was established by the finding of elevated basal serum 
gastrin levels on 6 occasions, increase in serum gastrin levels follow- 
ing secretin injection and calcium infusion, and of elevated basal 
serum gastrin levels following total gastrectomy (radioimmu- 
noassay of gastrin was performed by R. Arnold, M.D., Department 
of Internal Medicine, University of G6ttingen). 
Preparation of Biopsy Specimens. The panendoscope 7089 P from 
ACMI (Wappler, Munich) was used, with straight optics and a 
biopsy forceps with a spike (2.9 ram), in a modification of type 
7035 A. The jaws of the forceps were longer (3.9 mm) and deeper 
(0.9 ram) than the original type so that larger biopsies could be 
obtained. Four biopsy specimens were taken from the body mucosa 
of each of the subjects. Three of them were used for mueosal 
histamine determination and one for microscopical examination. 
The samples for histamine assay were weighed immediately after 
withdrawal on a microbalance (Sartorius, Type2774) and 
suspended each in 4 ml 0.4 M HC104. Until histamine determina- 
tion these mixtures were kept at --20°C in a deep-freezer for no 
longer than two weeks. 
Drugs and Reagents. Before endoscopy, the patients drank 1-2 ml 
SAB-Simplex ® (Parke-Davis) dissoIved in 50 ml tap water (0.6 mt 
SAB-Simplex® contained 40 mg dimethylpolysiloxane, 0.1mg so- 
dium saccharin, 1.2 mg sodium cyclamate). As premedication 
15 min before starting endoscopy, the patients were given i.v. atrop- 
ine (0.01 mg/kg), hyoscine-N-butylbromide (0.3 mg/kg), triflupro- 
mazine hydrochloride (0.15 mg/kg) and diazepam (0.1 mg/kg). 
None of these drugs caused significant histamine release which 
might have lowered gastric histamine concentration (Lorenz et al., 
1974). Only the substances described by Lorenz et al. (1972a, 
1974a) were used, as reagents in order to exclude impurities inter- 
fering with the assay. Twice-distilled water was prepared in a quartz 
still (K6ttermann Ltd.). 
Methods 
Fluorometric Assay of Histamine in Biopsy Specimens 
Histamine was determined according to a modification of our Dow- 
ex-method (Lorenz et al., 1970). The modification was necessary 
in order to increase the sensitivity of the assay for measuring 
the amine only in a few milligrams of tissue (Lorenz et al., 1975). 
The perchloric acid mixtures containing the biopsy specimens were 
homogenised with an Ultraturrax homogenizer using a microshaft 
TP 10 N. The total homogenate which showed a consistency of 
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turbid water was applied to the Dowex columns without prior 
centrifugation but only after adjustment to pH 6.5 by 5 M NaOH 
and 0.1 M sodium phosphate buffer (pH 6.5). After elution of 
histamine from the columns, condensation with 0.1% o-phthaldial- 
dehyde was carried out to lower the reagent blanks and to increase 
the sensitivity of the assay (Lorenz et al., 1976b). Thanks to a 
new photomultiplier used (Lorenz et al., 1974a), very small slide 
widths could be applied on the Zeiss fluorometer. Histamine was 
expressed as pg histamine dihydrochloride/g. 
Miscellaneous Techniques to Ensure Precision and Accuracy of the 
Histamine Determination. A fourth sample was obtained for mi- 
croscopical examination from the area where the three biopsy speci- 
mens were taken for histamine assay. This enabled to assess the 
depth of the mucosal sample and to establish the pathological 
diagnosis. The techniques involved are described by Rohde et al. 
(1976 b). The precision and accuracy of the histamine determination 
were tested both within the same day and from day to day (quality 
control). The results of these studies were published in detail else- 
widths could be applied on the Zelss fluorometer. Histamine was 
expressed as lag histamine dihydrochloride/g. 
Statistical Methods. Since the frequency distribution of the mucosal 
histamine contents in duodenal ulcer patients diverged considerably 
from normal, the median-percentile system was used for parameters 
of location and variance. Significance was tested by means of the 
Mann-Whitney-U test, which is suitable for non-parametric data 
(Sachs, 1974), 
Results 
1. Histamine Concentrations in Body Mucosa 
of Control Subjects 
In 31 control subjects, the histamine content of the 
body mucosa was 40.7 (31.4-46.1) pg/g fresh weight 
(median, lst-3rd quartile). This is a very high hista- 
10 
5 
"5 
E 
Z 
0 
control subjects duodenal ulcer patients 
10 
m 
n=21 
f ~=42.6 
I 
1 
o 
0 20 40 60 
n=17 
_ g=30.5 
0 20 40 60 80 
Mucosal histamine concentration L/ug/g J 
Fig. 1. Histograms of histamine concentrations in human corpus 
mncosa of control subjects and duodenal ulcer patients. Only male 
subjects were included. 2 = median. Statistical significance (Mann- 
Whitney test) between the two groups of individuals p<0.025 
mine concentration compared to that of other human 
tissues (Lorenz et at., 1973). The values were fairly 
normally distributed, as shown in Figure 1 for male 
subjects, but the same was true for the whole sample 
of" normal" subjects. There existed no obvious corre- 
lation between histamine levels and age, though the 
small number of subjects in the different groups may 
not have been sufficient for reliable calculation of 
statistical significance (Table 4). 
In male control subjects the mucosal histamine 
content attained 42.6 (3t.449.6) gg/g (n=21) and 
in female controls 35.8 (24.5-46.3) gg/g (n= 10). The 
difference of 16% between males and females was 
not statistically significant. 
Table 4, Histamine concentrations in human corpus mucosa of control subjects and duodenat 
ulcer patients depending on age. Only male subjects were included. Statistical significance 
(Mann-Whitney test) between the two groups of individuals: * p < 0,1, ** p < 0.2 
Diagnosis n Histamine content (lag/g) 
<20 20-34 35-49 50-64 65-79 > 79 years 
Control 1 33.5 22.7 23.2 35.6 
subjects 2 30.3 31.4 41.1 
3 40.9 37.8 
4 44.4 40.7 
5 45.7 49.5 
6 45.9 55.6 
7 46.3 
8 51.2 
31,8 
61.0 
76.8 
43.3 
Median - 45.1" 39.3** 38.3 61.0 -- 
Patients 1 71.5 21.7 22.3 24.0 26.7 - 
with 2 24.5 23.1 30.5 
duodenal 3 37.6 25.0 33.8 
ulcer 4 38.1 26.3 
5 42.5 29.8 
6 47.7 
7 51.4 
Median - 37.6 26.3 30.5 - - 
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2. Histamine Concentrations in Corpus M cosa 
of Patients with Chronic Duodenal Ulcer 
In this group of patients values can be presented only 
for male subjects, since there was only one woman. 
The mucosal histamine content in 17 males was 30.5 
(24.0-42.5) gg/g (median, lst--3rd quartile). The fre- 
quency distribution of the histamine values, however, 
was far from normal (Fig. 1) and corresponded more 
to a log-normal distribution. By the Mann-Whitney 
test, the mucosal histamine concentration in duodenal 
ulcer patients was found to be significantly by 30% 
lower (p<0.025) than in male control subjects 
(Fig. 1). 
As in control subjects there was no detectable 
correlation between mucosal histamine content and 
age in duodenal ulcer patients (Table 4). It seemed 
remarkable however that these two groups of individ- 
uals were really well matched for age. The difference 
in the mucosal histamine content between the two 
groups of patients could be demonstrated in all age 
groups which contained more than one individual 
(Table 4). Since the two groups of subjects were also 
well matched for weight, it seems fair to conclude 
that the difference in mucosal histamine concentra- 
tion between " ormal" control subjects and duoden- 
al ulcer patients was well established. 
The only female duodenal ulcer patient in our 
trial also had a prepyloric gastric ulcer (Dragstedt 
combination). Her mucosal histamine content was rel- 
atively high (81 gg/g). No conclusions can be drawn 
since we have no further experience of mucosal hista- 
mine levels in this disease in women. 
3. Histamine Concentrations in Corpus Mucosa 
of Patients with Various Gastric Diseases 
With the exception of one patient suffering from a 
Zollinger-Ellison syndrome, all other groups of pa- 
tients howed mucosal histamine concentrations high- 
er than those found in duodenal ulcer patients (Ta- 
ble 5). 
For direct comparison with the values in other 
groups of patients, the histamine concentrations in 
the 9 mate subjects with gastric ulcer should be noted: 
33.8 (32.8-47.4) lag/g (median, lst-3rd quartile). The 
only female subject with a gastric ulcer showed a 
mucosal histamine concentration f 28.8 gg/g. 
Patients with significant hiatal hernia were not 
different from "normal" control subjects with respect 
to their mucosal histamine content. Patients with cho- 
lecystitis (females only) had slightly higher values. 
Patients with gastric ancer (male subjects only) had 
slightly lower values than those found in the control 
Table 5. Histamine concentrations in human corpus mucosa of 
patients uffering from various gastro-intestinal diseases. Male and 
female subjects were included, Due to the small number of indi- 
viduals in the groups only for histamine values of male gastric ulcer 
patients tatistical significance could be calculated in comparison 
to control subjects and duodenal ulcer patients, Using the Mann- 
Whitney test in none of the two cases the differences were signifi- 
cant which should not be expected from the small number of patients 
(cf. those for control subjects aad duodenal ulcer patients) 
Diagnosis n Histamine content (~tg/g) 
Median or Range 
single values 
Gastric ulcer t0 37,2 15.5-98.8 
Hiatal hernia 6 37.2 13.4-66.8 
Gastric carcinoma 5 38,3 20.8-70,7 
Cholecystitis 4 48,0 31.7-71.0 
Gastric erosions 3 43,0 - 
Z.E. syndrome 1 13.3 - 
Atrophic gastritis 1 95,8 - 
Pancreatitis 1 40,3 --~ 
Oesophageal varices 1 63,0 
Obesity 2 40.9, 45.7 - 
subjects (Table 5). The single cases of Zollinger-Elli- 
son syndrome and of atrophic gastritis which have 
widely differing gastric histamine levels, do not per- 
mit to draw a definite conclusion and further investi- 
gation is needed. 
Finally, in the patients of the "escape" group 
(Table 3) histamine concentrations were in generally 
considerably higher than those in duodenal ulcer pa- 
tients. Mucosal histamine contents after vagotomy, 
in particular were found to be even higher than those 
observed in "normal" control subjects. This interest- 
ing result has been confirmed in a second prospective 
study to be published elsewhere in greater detail 
(Troidl et al., 1976b). 
Discussion 
1. Reliability of the Findings 
on Mucosal Histamine Concentrations 
in Various Groups of Patients 
with Gastrointestinal Disease 
There were three main problems which influenced 
the reliability of our results on mucosal histamine 
concentration: reliability of the histamine assay in 
biopsy specimens, relative thickness of mucosal 
biopsies and reliability of allotting patients to the 
various groups. 
Using a modification of the fluorometric method 
for histamine determination in tissues (Lorenz et al., 
1970), this amine could be determined in all gastric 
biopsy specimens investigated (Lorenz et al., 1975; 
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Lorenz et al., 1976b). The specificity of the assay 
has been assured by the usual tests of identity (Lorenz, 
1975; Lorenz et al., 1976), while the precision and 
relative accuracy of this technique have been shown 
by carrying out quality control experiments within 
the day and from day to day (Lorenz et al., 1975; 
Rohde et al., 1976b). There is thus no doubt about 
the reliability of the histamine assay in biopsy speci- 
mens. 
As shown by our group (Rohde t al., 1976b) 
and others (Heinkel et at., 1960; Kobayashi et al., 
1974) the relative thickness of mucosal particles ob- 
tained by biopsy varies considerably. Only in t8% 
of the specimens was the total thickness of the mucosa 
reached. In 55%, two-thirds, and in 27%, one-third 
of the body mucosa were obtained. This problem 
however seemed to be solved by taking three biopsy 
specimens from each of the subjects, so minimising 
the possibility that only superficial parts of the gastric 
mucosa were taken, since the relative thickness of 
mucosal particles was randomly distributed in the 
same patients. Furthermore, histamine and mast cells 
containing histamine (see below) have been found 
to  be fairly uniformly distributed throughout he 
thickness of the mucosa (Murray and Wyllie, 1964; 
Hgtkanson et al., 1970) or to have some degree of 
preference for the more superficial layers of the body 
mucosa (Smith, 1959; Rfisfinen, 1958). 
The third problem, i.e., establishing the diagnoses 
and to group patients into the various groups with 
sufficient accuracy, represented the greatest source 
of difficulty in our trial. Initially it seemed very" simple 
to define and to establish the diagnosis of a duodenal 
ucler, but for a variety of reasons it proved to be 
difficult in individual cases (Troidl et al., 1975). Simi- 
lar comments have been made by Goligher et at. 
(1972). In addition the detection of accompanying 
diseases and a critical evaluation of their significance 
was very laborious and always contained an element 
of subjectivity and personal bias. The previous history 
of a patient sometimes contained conflicting informa- 
tion which made it difficult o include him in a distinct 
group in our trial. For example, can a patient be 
considered to be a "normal" control subject if he 
has had significant "gastritis" for a relatively long 
period several years ago? In our panel discussion a
new dimension was introduced bythe realisation that, 
aside from other attributes, human beings differ from 
guinea-pigs mainly by their personal histories! On 
account of all these difficulties it was important that 
the values for the mucosal histamine concentrations 
should be added to the other data of each individual 
patient only after the final decision had been made 
about his belonging to one or another group in our 
trial. 
2. Histamine Concentrations in .Human Gastric Mucosa :
Alteration in Duodenal Ulcer Disease 
and Hypotheses about its Cause 
and Clinical Significance 
In this investigation mucosal histamine concentra- 
tions were determined in a relatively large number 
of human subjects. Samples of gastric mucosa were 
taken under more favourable conditions (i.e. closer 
to normal physiological conditions) than has been 
the case in all other previous studies. This enabled 
us to conclude at a relatively high reliability that 
the histamine content in "normal" human gastric 
mucosa was indeed very high and that it was signifi- 
cantly different from normal in duodenal ulcer dis- 
ease. Since in any species except the rat (Kahlson 
et al., 1964) it is extremely difficult o alter the muco- 
sal histamine concentration by any treatment (cf. 
Lorenz and Pfleger, 1968) the decrease in histamine 
content in duodenal ulcer disease seems to be remark- 
able. 
To our knowledge, histamine in human gastric 
mucosa is localized exclusively in mast cells. Studies 
using fluorescent microscopy have shown that cells 
in this tissue which emit luminescence after treatment 
with o-phthaldialdehyde w re always mast cells if 
the sections were consecutively stained with toluidine 
blue (Hgtkanson et al., 1969). These observations were 
in contrast to the findings of Tobe and Tanaka (1972) 
who described histamine-induced fluorescence com- 
ing from parietal cells they did not exclude the possi- 
bility that the fluorescence which they observed origi- 
nated from mast cells closely related to parietal cells 
(toluidine blue staining was not done!) (Lorenz et 
al., 1971). According to R/isfinen (1958) the highest 
density of mast cells in human corpus mucosa is 
indeed found in the layers which also show the highest 
density of parietal cells. His finding that there is a 
lower density of "detectable" mast cells in duodenal 
ulcer patients than in normal subjects provides sup- 
port for our results (R~isfinen, 1958). 
Histamine in mast cells is stored histamine which 
has been predominantly measured in our study. The 
finding of a decrease in stored histamine  duodenal 
ulcer disease first led to the hypothesis that this might 
be due to an augmented histamine liberation in this 
disease. In short-term experiments indeed a decrease 
of tissue histamine content reflects histamine release, 
mast cell degranulation a d occurrence of the amine 
in body fluids (Lorenz et al., 1973a; Lorenz et al., 
1974b). Similar results were obtained from rat gastric 
mucosa where histamine is not secreted from mast 
cells but from enterochromaffin-like cells (Kahlson 
et al., 1964; Thunberg, 1967; Hfikanson et al., 1967; 
Lundell, 1974). Since duodenal ulcer disease is a chro- 
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nic long-lasting process, our hypothesis not (entire- 
ly) convincing, but nevertheless remains as a possible 
explanation for our findings. 
There is good evidence that duodenal ulcer disease 
is associated with increased vagal activity (Dragstedt, 
1962). In rats vagally stimulated gastric secretion is 
accompanied by histamine release from gastric muco- 
sa (Kahlson et al., 1967; Thunberg, 1967). Although 
the bulk of this histamine may be derived from ente- 
rochromaffin-like c lls, a part of it may also be liber- 
ated from the "atypical" mast cell in the more super- 
ficial layers of gastric mucosa (Thunberg, 1967; Aures 
et al., 1968), because vagally stimulated gastric secre- 
tion is indeed inhibited after degranulation of mucosal 
mast cells in rats (Hirvonen et al., 1967). Mast cell 
degranulation furthermore is observed in experimen- 
tal gastro-duodenal ulcers produced by stress in rats 
(Guth and Hall, 1968; Guth and Kozbur, 1968, 1969) 
and this process is largely blocked by vagotomy. None 
of these arguments provides clear evidence of vagally 
stimulated histamine release in human subjects-in 
particular, in duodenal ulcer patients but they do not 
exclude the possibility that our hypothesis of an 
augmented histamine release in duodenal ulcer disease 
might be correct. It would then be expected that the 
mucosal histamine content of duodenal ulcer patients 
increase after vagotomy, which does in fact happen 
(Troidl et al., 1975a, 1975b). This finding increases 
the chances that our hypothesis i correct. 
A second hypothesis to explain our findings is 
that of decreased histamine formation in duodenal ul- 
cer disease. It is difficult to accept this idea at present 
for the following reasons. Firstly, it is by no means 
accepted that histamine be formed in human gastric 
mucosa (Lorenz et al., 1976c). The existence of a 
specific histidine decarboxylase in human gastric mu- 
cosa has been both accepted and denied. The exis- 
tence of a non-specific histidine decarboxylase has 
been shown by all investigators so far but its phys- 
iological significance has been frequently questioned 
(for a review of the argmnents, see Lorenz et al., 
1976c). Secondly, the only species which possesses 
a high activity of specific histidine decarboxylase in 
gastric mucosa is the rat. In that species vagal stimula- 
tion does not depress histamine formation but en- 
hances histidine decarboxylase activity (Kahlson et 
al., 1967; Thunberg, 1967). Thus the hypothesis seems 
unconvincing that histamine formation is decreased 
in duodenal ulcer disease. 
A third hypothesis that there exists an increased 
inactivation of gastric histamine in duodenal ulcer dis- 
ease'. Barth et al. (1977) however found that histamine 
methyltransferase activity-the only enzyme at present 
known to inactivate histamine in human gastric mu- 
cosa-is significantly diminished in the corpus mucosa 
of duodenal ulcer patients. Thus this hypothesis also 
lacks conviction. 
The effects of histamine Ha-receptor antagonists, 
metiamide and cimetidine on healing duodenal ulcers 
(multicentre study, 1975) could be explained by two 
different mechanisms, namely in that (1) it prevents 
abnormally large amounts of histamine to be released 
at the H2-receptors of the parietal cells. (2) or that 
it activates histamine methyltransferase in gastric mu- 
cosa which, in turn, leads to faster inactivation of 
the released histamine. In vitro this effect was shown 
by Barth et al. (1973, 1973a). In vivo there are find- 
ings which support his hypothesis (Thjodleifsson and 
Wormsley, 1975). 
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